Asked by: Baroness Walmsley (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether NHS England's forthcoming quality strategy will include a new model for financial incentives in the NHS, including specialised, secondary, primary and community care.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The new NHS Quality Strategy will build on the 10-Year Health Plan and Dr Penny Dash’s review of patient safety across the health and care landscape. The 10-Year Health Plan commits to using sharper financial incentives to deliver value and improve outcomes. We expect the NHS Quality Strategy will reference, alongside other interventions, how the Department and NHS England will develop these incentives to ensure they drive high quality care across the National Health Service.
Asked by: Baroness Walmsley (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to increase opportunities to diagnose chronic kidney disease early, particularly through increased urine albumin to creatinine ratio testing.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England is delivering a comprehensive programme to improve the diagnosis, treatment, and outcomes of people with kidney disease. In 2023, NHS England published a renal services transformation toolkit to support earlier identification of chronic kidney disease and more joined up services. These changes are intended to make it easier to deliver improvements along the whole patient pathway, including earlier diagnosis and treatment, that can potentially prevent or delay the need for dialysis and transplant further downstream in the pathway.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing clinical guidance and quality standards. NICE’s guidance on chronic kidney disease includes guidance on the use of annual urine albumin-creatine ratio tests as the preferred method to detect and monitor kidney disease. The guidance is available on the NICE website.
Asked by: Baroness Walmsley (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure the uptake of guidelines-directed medical therapies in primary care for (1) cardiovascular disease, (2) diabetes, and (3) chronic kidney disease.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) published a strategy in March 2025 setting out a collective ambition for improving uptake and adoption of NICE guidance by the health and care system over the next three years. The strategy aims to improve the uptake and adoption of NICE guidance in priority areas which align with the National Health Service 10-Year Health Plan by 10% by March 2029. This includes guidance on cardiovascular disease and diabetes, further details on which can be found on the NICE website.
In 2023, NHS England published a renal services transformation toolkit to support earlier identification of chronic kidney disease and more joined up services. Eight commissioned regional renal clinical networks are implementing this toolkit, in collaboration with providers. The regional networks are designed to improve care for kidney patients by standardizing treatment, reducing health inequalities, and promoting best practices, including for medical therapy use, across hospitals, commissioners, and specialists.
Asked by: Baroness Walmsley (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to ensure that cigarette filter tips are included in the definition of relevant products in the Tobacco and Vapes Bill that are not allowed to be advertised or promoted.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Tobacco Advertising and Promotion Act 2002 prohibits any advertisements whose purpose or effect is to promote a tobacco product. The Advertising Standards Authority’s rules state that marketing communications for cigarette filters should not encourage people to start smoking or increase their consumption.
The Tobacco and Vapes Bill restates the restrictions on the advertising of tobacco products. We have no current plans to introduce additional restrictions on the advertising of filters through the bill.
Asked by: Baroness Walmsley (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what percentage of nurses dropped out of (1) all nurse training, (2) paediatric nurse training, (3) adult nurse training, and (4) mental health nurse training, in the most recent year for which figures are available.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
The Higher Education Statistics Agency publish the proportion of nursing entrants to undergraduate courses that are no longer in higher education. The following table shows the proportion of United Kingdom domiciled undergraduate nursing entrants who are no longer in higher education 2019/20. The rates in will not include students that have transferred to a course in another subject. Non-continuation rates are not available at the level of specific nursing professions.
| Proportion of entrants that are no longer in higher education |
Young students (21 years old and under) | 4.70% |
Mature students (over 21 years old) | 7.10% |
Source: The Higher Education Statistics Agency Non-continuation rates 2022.